memo - Magazine of European Medical Oncology

Approaching personalized cancer medicine

G. Gastl

CECOG at ASCO 2008

Dagmar Just

Proteomics, a new tool to monitor cancer therapy?

J. Loeffler-Ragg, B. Sarg, D. Mueller, T. Auer, H. Lindner, H. Zwierzina

Personalized medicine – p53 gene analysis for prediction of response to neoadjuvant therapy in esophageal cancer

D. Kandioler

Can we tailor neoadjuvant (primary) systemic therapy for breast cancer?

A. Eniu

Striking response with bevacizumab and chemotherapy in a woman with heavily pretreated breast cancer: a case presentation

K. Prassl, A. Sahanic, B. Reicher, H. Denz, M. Freund, M. Fiegl

Ocular abnormality as the first sign of metastatic breast cancer: the presentation of two cases

Z. Kahán, Á. Szabó, A. Cserháti

"Old tricks and new procedures" – a report from the 34th Annual Meeting of the European Group for Blood and Marrow Transplantation EBMT, March 30 – April 2, 2008, Florence, Italy

E. Willenbacher, W. Willenbacher

Targetable oncogenic pathways in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma

A. Tzankov

Treatment options in localised and metastatic renal cell carcinoma

A. P. Berger, A. Hobisch

Individualized molecular cancer therapy based on radiolabelled somatostatin analogues

M. Gabriel, U. Andergassen, I. J. Virgolini

Therapeutic options for the treatment of infections with multiresistant grampositive bacteria in oncological patients

G. Fritsche, G. Weiss

Announcement